An Exploration of Factors Influencing Adherence to Highly Active Antiretroviral Therapy (HAART) Among People Living With HIV/AIDS in Northern Thailand
January 3, 2011
The chief purpose of the current report, the first of a three-phase study of the experiences of people living with HIV/AIDS (PLWHA) in northern Thailand, "was to gain an in-depth understanding of the factors contributing to adherence in patients taking highly active antiretroviral therapy (HAART)," the authors wrote. The knowledge gained was used in Phase II "to inform a number of interventions aimed at improving medication adherence in patients commencing HAART for the first time."
The study's subjects were 32 PLWHA over age 18 who had taken HAART for at least three months. The project's qualitative component used a multiple case study approach to report on the experiences of patients on HAART. Its quantitative component included the Morisky Medication Adherence Scale and a demographic survey of respondents; these data provided descriptive statistics of the research population and assisted in the interpretation of the qualitative data.
12.2010; Vol. 22; No. 12: P. 1555-1561; Ganigah Ruanjahn; David Roberts; Leanne Monterosso
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)